Prostate Cancer
What is the clinical significance of FDG unexpected uptake in the prostate in patients undergoing PET/CT for other malignancies? - Abstract
February 21, 2014
Can single positive core prostate cancer at biopsy be considered a low-risk disease after radical prostatectomy? - Abstract
February 21, 2014
Metastatic castration-resistant prostate cancer (CRPC): Preclinical and clinical evidence for the sequential use of novel therapeutics - Abstract
February 21, 2014
Enzalutamide (Xtandi) for patients with metastatic, resistant prostate cancer - Abstract
February 21, 2014
Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancer - Abstract
February 19, 2014
Diagnostic value of biparametric MRI as an adjunct to PSA-based detection of prostate cancer in men without prior biopsies - Abstract
February 19, 2014
Three-dimensional surgical navigation model with Tile-Pro display during robotic radical prostatectomy - Abstract
February 19, 2014
Accuracy of multiparametric MRI for prostate cancer detection: A meta-analysis - Abstract
February 19, 2014
Standards for prostate biopsy - Abstract
February 19, 2014